ANZ Group Holdings Ltd
ANZ
BHP Group Ltd
BHP
Westpac Banking Corp
WBC
CommBank
CBA
Rio Tinto Ltd
RIO
Biotron Ltd is a biotechnology company. It is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.